No PCa drugs yet, but some might be happy with the list. My wife is on Xarelto.
nbcnews.com/health/health-c...
The drugs selected to undergo negotiations are:
Eliquis, a blood thinner
Xarelto, a blood thinner
Januvia, a diabetes drug
Jardiance, a diabetes drug
Enbrel, a rheumatoid arthritis drug
Imbruvica, a drug for blood cancers
Farxiga, a drug for diabetes, heart failure and chronic kidney disease
Entresto, a heart failure drug
Stelara, a drug for psoriasis and Crohn's disease
Fiasp and NovoLog, for diabetes
Together, the 10 drugs selected accounted for $50.5 billion, or 20%, of Medicare Part D spending from June 1, 2022, to May 31, according to the CMS.
-Patrick